Work

Phase II Trial of Single Agent Panobinostat (LBH589) In Relapsed or Relapsed/Refractory Waldenstrom Macroglobulinemia

Year: 2010

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v116.21.3952.3952

Authors: Irene Ghobrial, Tiffany Poon, Meghan Rourke, Stacey Chuma, Janet Kunsman, Ranjit Banwait, Amy Sam, Diane Warren, Kenneth C. Anderson, Paul Richardson, Steven P. Treon, Jeffrey Matous

Institutions: Harvard University, Dana-Farber Cancer Institute, Rocky Mountain Cancer Centers

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2587908274

FWCI: 0.909

Cites:

Cited by: 12

Related to: 10